Aachen papers per year
Papers 539
-
Identifying Pregnancies at Higher Risk for HPA-1a Alloimmunization and Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT): An International, Prospective, Natural History Study
Emilie Vander Haar, Courtney Abshier Ware, Gwen Allen, Róisín Armstrong, Michael Bombara, David N. Dhanraj, +12 more
2citations -
Transplant Outcomes for Acute Myeloid Leukemia or Myelodysplastic Syndromes Secondary to Acquired Aplastic Anemia or Paroxysmal Nocturnal Hemoglobinuria: A Report from the EBMT Severe Aplastic Anemia Working Party
Pedro Henrique Prata, Dirk‐Jan Eikema, Brian Piepenbroek, Austin Gladston Kulasekararaj, Beatrice Drexler, Jennifer M.L. Tjon, +19 more
2citations -
Graft-Versus-Host Disease (GvHD) and Steroid-Refractory GvHD after Allogeneic Hematopoietic Stem Cell Transplantation: A Large Real-World EBMT-Based Epidemiology and Treatment Pattern Study
Selim Corbacioglu, Jarl Mooyaart, Emmanuelle Polge, William Boreland, Jessica Lemaitre, Christophe Peczynski, +20 more
2citations -
Optimization of Targeted Lipid Nanoparticle for the Treatment of RUNX1::ETO Driven AML2024 Blood conference-abstract Biochemistry, Genetics and Molecular Biology RNA Interference and Gene Delivery Open access
L. Daniel Mata Casimiro, Manisha du Plessis, Dennis Unthan, Heyang Zhang, Matthias Barz, Raymond Michel Schiffelers, +1 more
2citations -
Pharmacodynamic Signatures and Correlatives of Response in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Talquetamab or Teclistamab Plus Daratumumab and Pomalidomide
Deeksha Vishwamitra, Sheri Skerget, Kalpana K. Bakshi, Lien Vandenberk, Weili Sun, Jaszianne A. Tolbert, +26 more
2citations -
Oral Iptacopan Monotherapy Leads to Long-Term Improvements in Patient (Pt)-Reported Health-Related Quality of Life (HRQoL) and Investigator-Assessed Signs and Symptoms of Paroxysmal Nocturnal Hemoglobinuria (PNH): 48-Week (Wk) Results from the Phase III APPLY-PNH and APPOINT-PNH Trials
Antonio Maria Risitano, Bing Han, Austin Gladston Kulasekararaj, Yasutaka Ueda, Phillip Scheinberg, Jaroslaw Pawel Maciejewski, +7 more
2citations -
Specific Gut Microbiome Changes in Myelodysplastic Neoplasms Linked to Inflammation2024 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Gut microbiota and health
Ekaterina Balaian, Katja Sockel, Manja Wobus, Maria Uhlig, Matthias Wolfgang Groß, Sebastian Zeißig, +3 more
2citations -
Postpartum Hemorrhage in Women with Von Willebrand Disease after Enhanced Prophylactic Clotting Factor Suppletion: The Pregnancy and Inherited Bleeding Disorders Study (PRIDES)
Anne de Vaan, Jeroen C.J. Eikenboom, Marieke J.H.A. Kruip, Marieke C. Punt, Michiel Coppens, Laurens Nieuwenhuizen, +10 more
2citations -
High complete response rates, low dropout rate, and low-grade toxicities in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) receiving GLPG5101, a fresh, early memory-enriched CAR T-cell therapy with a 7-day vein-to-vein time: Results from the ATALANTA-1 DLBCL cohort
Joost S.P. Vermaat, Pim G. N. J. Mutsaers, Sébastien Anguille, Maria Theresa Kuipers, Évelyne Willems, Tim J. A. Dekker, +14 more
2citations -
A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat Versus Best Available Therapy (BAT) in Patients with Intermediate-2 (Int-2) or High-Risk Myelofibrosis (MF) Refractory to Janus Kinase Inhibitor (JAKi)
John O Mascarenhas, Claire N. Harrison, Jean‐Jacques Kiladjian, Rami S. Komrokji, Steffen Koschmieder, Alessandro Maria Vannucchi, +9 more
1citations -
Consensus-Based Best Practice Recommendations for Myelofibrosis Management in Routine Clinical Practice with a Focus on Patients with Cytopenias: Systematic Literature Review and Clinical Practice Recommendations from a Global Consensus Group
Claire N. Harrison, Prithviraj Bose, Martin H. Ellis, Vikas K Gupta, Jean‐Jacques Kiladjian, John O Mascarenhas, +3 more
1citations -
Health-Related Quality of Life of CML Patients Under 2nd or 3rd Line Bosutinib Is Not Impaired Significantly By Gastrointestinal Toxicity (GI Tox) but Influenced By Sex - Results from a Subanalysis of the Bosutinib Dose Optimization (BODO) Study (CML-VII) Trial of the German CML Study Group
Susanne Isfort, Dominik Georg Friedrich Wolf, Lino Lars Teichmann, Martina Margrit Crysandt, Andreas Burchert, Andreas Hochhaus, +11 more
1citations
Most active Aachen authors
-
Tim H. Brümmendorf 16,145 citations overall53 papers
-
Steffen Koschmieder 11,677 citations overall46 papers
-
Jens Panse 10,288 citations overall40 papers
-
Joost S.P. Vermaat 3,482 citations overall40 papers
-
Linda Köster 1,844 citations overall39 papers
-
Edgar Jost 3,752 citations overall31 papers
-
Dirk‐Jan Eikema 1,017 citations overall29 papers
-
Hendrik Veelken 10,266 citations overall25 papers
-
Fabian Beier 3,900 citations overall23 papers
-
Martina Margrit Crysandt 2,348 citations overall23 papers
-
Luuk A. Gras 5,079 citations overall22 papers
-
JESSICA T. VERMEULEN 10,466 citations overall20 papers
-
Liesbeth C. de Wreede 4,718 citations overall18 papers
-
Régis Peffault de Latour 20,463 citations overall14 papers
-
Antonio Maria Risitano 16,882 citations overall14 papers